Skip to main content

Table 1 Demographic and preoperative data

From: Benefits of ultra-fast-track anesthesia in left ventricular assist device implantation: a retrospective, propensity score matched cohort study of a four-year single center experience

 

Unmatched

Matched

 
 

LVAD conv

LVAD ultra

p-values

LVAD match

LVAD ultra

p-values

Patients failed UFTA (n = 2)

n = 30

n = 13

n = 13

n = 13

Age

65.2 ± 8.4

61.1 ± 7.9

0.108

64.1 ± 4.8

61.1 ± 7.9

0.485

63.5 ± 0.5

Female n (%)

6 (20)

2 (15.4)

1.000

1 (7.8)

2 (15.4)

0.500

1(50)

BMI kg/m2

29.5 ± 4.2

26.1 ± 3.1

0.009

26.3 ± 3.0

26.1 ± 3.1

0.735

25.8 ± 1.2

PAD n (%)

7 (23.3)

5 (38.5)

0.460

5 (38.5)

5 (38.5)

1.000

1(50)

creatinine (mg/dl)

1.3 ± 0.2

1.1 ± 0.3

0.032

1.1 ± 0.2

1.1 ± 0.3

0.907

1.1 ± 0.2

GFR mL/min.

65.6 ± 6.4

66.5 ± 6.5

0.673

65.3 ± 6.8

66.5 ± 6.5

0.693

65.5 ± 0.5

Prior HD

2 (6.7)

0

1.000

0

0

-

0

COPD ≤ II n (%)

8 (26.7)

5 (38.5)

0.485

3 (23.1)

5 (38.5)

0.727

1(50)

COPD > II n (%)

4 (6.7)

0

0.297

0

0

-

0

FEV1 %

64.8 ± 7.1

74.4 ± 8.5

0.001

68.5 ± 6.2

74.4 ± 8.5

0.068

69.5 ± 1.5

CVA

2 (6.7)

0

1.000

0

0

-

0

DM n (%)

12 (40)

2 (15.3)

0.163

4 (30.8)

2 (15.3)

0.625

2(100)

Nicotine

20 (66.7)

8 (61.5)

0.742

11 (84.6)

8 (61.5)

0.453

2(100)

DCM n (%)

6 (20)

2 (15.4)

1.000

3 (23.1)

2 (15.4)

1.000

0

ICM n (%)

24 (80)

11 (84.6)

1.000

10 (76.7)

11 (84.6)

1.000

2(100)

CI L/min/m2

2.4 ± 0.7

3.0 ± 1.6

0.651

2.3 ± 1

3.0 ± 1.6

0.251

2.9 ± 1

MPAP mmHg

28.9 ± 11.4

30.6 ± 11.6

0.758

34.5 ± 9.1

30.6 ± 11.6

0.198

30.5 ± 0.5

PCWP mmHg

19.3 ± 9.8

21.3 ± 9.4

0.614

23.8 ± 8.1

21.3 ± 9.4

0.330

24.5 ± 1.5

LVEF %

21.4 ± 6.7

17.7 ± 4.1

0.088

19.1 ± 4.7

17.7 ± 4.1

0.715

20 ± 2

RVEDD1 mm

38.9 ± 5.7

37.4 ± 6.1

0.389

37.5 ± 4.9

37.4 ± 6.1

0.984

38.5 ± 0.5

TAPSE mm

15.7 ± 3.1

14.7 ± 5.6

0.212

15.8 ± 4.1

14.7 ± 5.6

0.552

16.5 ± 0.5

DT n (%)

18 (60)

6 (46.2)

0.509

10 (76.9.6)

6 (46.1)

0.453

0

BTC/BTT n (%)

12 (40)

7 (53.8)

0.509

3 (23.1)

7 (53.8)

0.453

2(100)

EuroSCORE II %

14.1 ± 11.6

13.4 ± 8.1

0.820

14.2 ± 7.8

13.4 ± 8.1

0.786

15.5 ± 0.5

INTERMACS Level n (%):

 Level 3

14 (46.7)

4(30.8)

0.502

2 (15.4)

4 (30.8)

0.431

0

 Level 4

16 (53.3)

9(69.2)

0.502

11 (84.6)

9 (69.2)

0.431

2(100)

  1. Continuous variables are expressed as means ± standard deviation (SD). Categorical variables are expressed as percentages and absolute numbers. Bold writing indicates significance
  2. BMI body-mass-index, BTC bridge to candidacy, BTT bridge to transplantation, CI cardiac index, CPB time cardiopulmonary bypass time (min.), COPD chronic obstructive pulmonary disease, CVA cerebrovascular accident, DCM dilated cardiomyopathy, DM diabetes mellitus, DT destination therapy, EuroSCORE II European System for Cardiac Operative Risk Evaluation II, FEV1% ratio of forced expiratory volume in 1 s (FEV1)/ Forced vital capacity (FVC), GFR glomerular filtration rate (mL/min.), HD hemodialysis, ICM ischemic cardiomyopathy, INTERMACS Interagency Registry for Mechanically Assisted Circulatory Support, LVEF left ventricular ejection fraction, MPAP mean pulmonary artery pressure, PAD peripheral artery disease, PCWP pulmonary capillary wedge pressure (mmHg), RVEDD1 right ventricular end-diastolic basal diameter (mm), TAPSE tricuspid annular plane systolic excursion (mm)
Back to article page

Journal of Cardiothoracic Surgery

ISSN: 1749-8090

Contact us